Moderna to Supply up to 500 Million COVID-19 Vaccine Doses for Low-Income Countries
Low-income countries can benefit from the latest Moderna – Gavi agreement, which is set up to distribute up to 500
Read moreLow-income countries can benefit from the latest Moderna – Gavi agreement, which is set up to distribute up to 500
Read moreThe Code of Practice of the Association of the British Pharmaceutical Industry (ABPI) lays down the rules that the industry
Read morePfizer announced on Wednesday, the acquisition of Amplyx Pharmaceuticals, Inc., a privately-owned company focused on the engineering of treatments for
Read moreThermo Fisher Scientific, a global leader in serving science, introduced the Helios 5 EXL Wafer DualBeam, which is engineered to
Read moreBristol-Myers Squibb is investing in a brand new cell therapy facility which will be located at the Leiden Bio Science
Read morePhico Therapeutics (‘Phico’), a British biotech company developing engineered phage technologies as the foundation of a new wave of antibiotics
Read moreGSK and Vir Biotechnology have announced that the EMA has started a review of the dual-action monoclonal Antibody VIR-7831 for
Read moreEvotec SE, a publicly listed drug discovery and development company headquartered in Hamburg, Germany, has launched beLAB2122, a translational $
Read moreSanofi revealed on April 12, 2021, that it will spend €400 million over five years in Singapore to build a
Read moreExscientia, a leading artificial intelligence (AI) driven pharmatech company based in Oxford, England, announced that the first AI-designed molecule for
Read more